Search Results - "Maurer, David H."

P0070 Extracting histotrac data to excel reduces the time required to perform virtual matches by semi-automation by Tumer, Gizem, Thorson, Randall, Maurer, David H, Gatewood, Lael, Lougee, Michael, Cohn, Claudia S

“…Aim The new kidney allocation system has increased the demand for virtual crossmatches (vxm) at our hospital. A manual vxm can be a cumbersome process which…”
Get full text

12-P by Davidson, Maurine L, Stewart, Mary B, Lyrenmann, Toni J, Scalf, Carolynn, Maurer, David H

“…Aim Use Real Time PCR (RT-PCR) to verify the identity of donor cells used in flow crossmatch. Methods Following lymphocyte isolation for flow crossmatch, an…”
Get full text

Microchimerism and rejection in clinical transplantation by Elwood, E T, Larsen, C P, Maurer, D H, Routenberg, K L, Neylan, J F, Whelchel, J D, O'Brien, D P, Pearson, T C

“…Haemopoietic microchimerism has been identified in recipients of solid-organ transplants and is thought by some to be critical for the development and…”
Get more information

P040 Post-transplant De-novo donor specific antibody to HLA-B8, of unknown clinical significance by Tumer, Gizem, Maurer, David H., Dunn, Ty

“…Clinical History: A 62 year-old male with chronic glomerulonephritis underwent kidney transplant from a donation after cardiac death donor in Jan 2017. Cold…”
Get full text

P038 Human leukocyte antigen primer binding fluke leads to detection of rare allele by Helsene, Kirstie, Kremer, Meghan, Scalf, Carolynn, Tumer, Gizem, Maurer, David H.

Get full text

OR38 Unusual HLA a locus resolution for a patient with partial trisomy 6p syndrome by Carlson, Andrew, Kremer, Meghan, Scalf, Carolynn, Tumer, Gizem, Maurer, David H.

Get full text

12-P: VERIFICATION HLA TYPING: ARE YOU SURE YOU USED THE RIGHT CELLS IN THAT FLOW CROSSMATCH? by Davidson, Maurine L., Stewart, Mary B., Lyrenmann, Toni J., Scalf, Carolynn, Maurer, David H.

“…Use Real Time PCR (RT-PCR) to verify the identity of donor cells used in flow crossmatch. Following lymphocyte isolation for flow crossmatch, an aliquot of…”
Get full text

Quality Control for DNA Contamination in Laboratories Using PCR-Based Class II HLA Typing Methods by McCormack, Jeffrey M, Sherman, Martha L, Maurer, David H

“…Quality control (QC) in laboratories performing molecular histocompatibility class II typing often includes a polymerase chain reaction (PCR) approach for…”
Get full text

The use of gamma interferon to increase HLA antigen expression on cultured amniotic cells used for the prenatal diagnosis of 21-hydroxylase deficiency by Maurer, D H, Pollack, M S

Get more information

Prenatal diagnosis of 21-hydroxylase deficiency

Get more information

Preparing monolayers of non-adherent mammalian cells by Mattes, M J, Tanimoto, M, Pollack, M S, Maurer, D H

“…A simple method is described for preparing monolayers of non-adherent cells, using concanavalin A to bind the cells to wells of plastic microtest plates. The…”
Get more information

HLA typing used with cultured amniotic and chorionic villus cells for early prenatal diagnosis or parentage testing without one parent's availability by Callaway, C, Falcon, C, Grant, G, Maurer, D H, Auerbach, A D, Rosenwaks, Z, Pollack, M S

“…Like fetal fibroblasts and amniotic fluid cells, cultured chorionic villus cells can also be HLA typed with selected typing sera after preincubation with gamma…”
Get more information

Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation by Maurer, D H, Collins, W E, Hanke, J H, Van, M, Rich, R R, Pollack, M S

“…Recently, a number of laboratories have shown that gamma interferon (IFN-gamma) is a potent modulator of HLA class II antigen expression in a variety of cell…”
Get more information

The use of phytohemagglutinin-stimulated mononuclear cell subpopulations for HLA typing studies involving chronic myelogenous leukemia patients by Callaway, C, Maurer, D H, Brown, D, Fang, W, Fehir, K M, Pollack, M S

Get more information

HLA typing of amniotic fluid cells for the prenatal determination of therapeutic transplantation options for a fetus affected with adenosine deaminase deficiency by Pollack, M S, Maurer, D H, Mattes, M J, LeBlanc, D, Horowitz, S D, Hong, R

Get more information

The use of Epstein-Barr virus transformation for the establishment of class II positive cord blood cells for use in analysis of maternal sera by Maurer, D H, Baker, K, Sumaya, C V, Brown, D, Callaway, C, Pollack, M S

“…The use of Epstein-Barr virus transformed cord blood cells to detect maternal antibodies to neonatal class II DR and DQ antigens and to allotype the reacting…”
Get more information